Moderna Closer To Having Combined Flu & Covid Vaccine

June 11, 2024

Moderna is the only company with a positive Phase 3 flu and COVID combination vaccine.

Chief Executive Officer of Moderna, Stéphane Bancel, in a press release announcing the most recent data of a combination vaccine against flu and COVID-19. According to the late-stage trial, the combined shot appeared more effective than the existing individual flu and COVID-19 shots in a late-stage trial.

Why It Matters: Moderna, a biotech company, released Phase 3 data on Monday, the first company to share positive data for late-stage testing regarding a combined flu and COVID-19 shot – a feat currently sought after by other companies, such as Pfizer and Novavax. While development of the shot remains ongoing, Moderna hopes for regulatory approval this summer so the shot can be available to the public in 2025.

Read More: Moderna’s combination Covid, flu vaccine is more effective than existing shots in late-stage trial (CNBC)

by Emily Hooker, based in Texas